PTGDR2 and type 1 diabetes mellitus: Inhibition of GPR44 in human islets has the following effects: (1) reduced PGD2- and proinflammatory cytokine-induced apoptosis; (2) preserved islet grafts; and (3) improved glucose regulation in vivo in human islets exposed to a type 1 diabetes-like milieu.